Status:
RECRUITING
Lymphoedema and Nocturia/ Nocturnal Polyuria After Pelvic Lymph Node Dissection for Urogenital Cancer
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Lower Limb Lymphedema
Urogenital Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
After the treatment of urogenital cancer, a person may develop lymphoedema of the leg(s) and/ or midline region. Lymphoedema is the result of a dysfunction in the lymphatic system and is characterized...
Eligibility Criteria
Inclusion
- Patients included in the prospective observational study and developing lymphoedema within the first year after surgery
- Before inclusion, written informed consent must be given according to ICH/GCP, and national/local regulations.
- Inclusion criteria of the prospective observational study were:
- Non-metastatic urogenital cancer (i.e. prostate cancer or bladder cancer)
- Pelvic lymph node dissection
Exclusion
- same as for the prospective observational study:
- Radiological evidence of metastatic disease based on pelvic CT/MRI and bone scan
- Clinical signs of chronic venous insufficiency
Key Trial Info
Start Date :
January 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05266157
Start Date
January 21 2022
End Date
September 1 2024
Last Update
June 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Leuven, campus Gasthuisberg
Leuven, Flanders, Belgium, 3000